Back

Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs

29 August 2022 (17:15 - 17:45)
Organised by:
Congress Presentation Part of: Pharmacological and metabolic impact on ventricular arrhythmias Drug Treatment of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Gerrit Frommeyer

University Hospital of Munster, Munster (Germany)

3 More presentations in this session

Presentation thumbnail
Amiodarone and ventricular fibrillation amplitude of spectral area in patients with out-of-hospital cardiac arrest. Is there an effect?
Doctor F. Gentile (Pavia, IT)
Abstract Slides
Presentation thumbnail
Clinical features of drug-induced long QT syndrome in a large prospective cohort
Doctor J. Guerra (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Bariatric surgery reverses ventricular repolarisation heterogeneity in obesity: mechanistic insights into fat-related arrhythmic risk
Ms N. Herath (GB)
Abstract Slides

Access the full session

Session thumbnail
Pharmacological and metabolic impact on ventricular arrhythmias

The Event

Event poster

ESC Congress 2022

29 August 2022 17:15 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
The storm will pass…
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources